Arrowstreet Capital’s NantHealth, Inc NH Stock Holding History

Arrowstreet Capital’s Portfolio NH Stock Details NH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-6,724	Closed	-$326K	–	2641
2020 Q4	$326K	Sell	6,724 -10,829	-62%	-$407K	﹤0.01%	2104
2020 Q3	$616K	Buy	+17,553	New	+$990K	﹤0.01%	1964

Other funds holding NH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Arrowstreet Capital's NH Position: Q1 2021 in Review

Arrowstreet Capital sold out of NantHealth, Inc (NH) in Q1 2021, closing a stake of 6,724 shares — an estimated $326K sold.

Arrowstreet Capital first reported a position in NH in Q3 2020 and held it in 2 quarters. The position peaked at $616K in Q3 2020. 45 funds tracked by Wall St. Rank hold NH as of Q1 2021.

Arrowstreet Capital reported no remaining NantHealth, Inc position as of Q1 2021 after selling out during the quarter.
Arrowstreet Capital sold 6,724 NantHealth, Inc shares in Q1 2021, an estimated $326K.
Arrowstreet Capital first reported a position in NantHealth, Inc in Q3 2020 and held it in 2 quarters.
Arrowstreet Capital's NantHealth, Inc position peaked at $616K in Q3 2020.
45 funds tracked by Wall St. Rank held NantHealth, Inc as of Q1 2021.

Based on Arrowstreet Capital's 13F filing for Q1 2021, filed 14 May 2021.